← FDA Drug Approvals (Drugs@FDA)

EMPAGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LIMITED · Approved 2026-05-21

Drug application

FDA Application #

ANDA212371

Application type

Abbreviated New Drug Application (Generic)

Brand name

EMPAGLIFLOZIN

Generic name

Empagliflozin

Active ingredients

EMPAGLIFLOZIN

Dosage form

TABLET

Route

—

Marketing status

None (Tentative Approval)

Sponsor

AUROBINDO PHARMA LIMITED

First approval

2026-05-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown